Medication info
Nutra Tablets

Nutra Tablets

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Ankuk New Pharm Co., Ltd.
Appearance
Pale yellow oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201603986 · Approved 2016.06.27 · Insurance code 053600230

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medication after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.
Child dose
Children aged 12 years or older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medication for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medication should continue.

Ingredients

Manufacturer
Ankuk New Pharm Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute or chronic pain ranging from moderate to severe.

How to take

Adult dose

Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medication after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.

Child dose

Children aged 12 years or older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and the total should not exceed 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medication for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medication should continue.

Precautions

This medication may cause liver damage if taken by individuals who regularly consume more than three alcoholic beverages daily; it is essential to consult a physician or pharmacist. If a rash or hypersensitivity reaction occurs while taking this medication, it should be discontinued immediately, and a physician should be consulted. Tramadol, one of the active ingredients in this medication, may increase the risk of seizures if taken above the recommended dose, and this risk is higher when used with certain antidepressants or narcotics. Patients with acute or severe bronchial asthma may be at high risk for respiratory depression when taking this medication, so it should only be administered in a medically equipped facility. Concurrent use of this medication with alcohol or central nervous system depressants can lead to severe sedation, respiratory depression, and even death; therefore, such combinations should be avoided. Patients with elevated intracranial pressure or head injuries should be cautious as respiratory depression from this medication may worsen their symptoms. This medication can lead to physical and psychological dependence, so careful monitoring is required when used for long periods. Patients with impaired liver function should consult a physician before use, as the components of this medication may severely impact liver health. Patients with certain genetic metabolic traits may experience increased levels of active metabolites, leading to a higher risk of respiratory depression and should be cautious. This medication should not be given to children under 12 years of age or adolescents under 18 years of age who have undergone tonsillectomy or adenoidectomy; adolescents aged 12 to under 18 should also avoid it if they have specific risk factors. This medication may induce sleep apnea or hypoxia, requiring ongoing evaluation of symptoms and possible dosage adjustments or discontinuation. During treatment, there is a risk of hyponatremia, so elderly patients or those with risk factors should have their serum sodium levels checked periodically. This medication interacts with several other drugs, which may increase the risk of seizures, serotonin syndrome, or respiratory depression; it is necessary to inform healthcare providers of all medications being taken. Pregnant or breastfeeding women should consult a physician before taking this medication, as it may pose risks to the fetus or newborn; it is advisable to avoid its use during breastfeeding. Caution is advised due to potential drowsiness or dizziness while driving or operating machinery after taking this medication. Overdosing on this medication can result in severe respiratory depression, seizures, liver damage, and even fatal side effects; therefore, prescribed dosages should always be adhered to, and emergency care should be sought immediately in case of overdose. Store this medication out of reach of children to prevent accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, fatal respiratory suppression, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, sensory loss, tremor, paresthesia, attention deficit, syncope, memory disorders, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, pupil constriction, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, weakness, chest pain, abnormal emotions, chills, chest discomfort, malaise, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic response, Stevens-Johnson syndrome, toxic epidermal necrolysis, impact on emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hypoprothrombinemia, fatigue glutamic acidosis, high anionic gap metabolic acidosis, fixed rash, fever, edema, rigidity, syncope, congestive heart failure, stupor, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, multiple organ failure, intentional overdose, paralytic ileus, cholecystitis, abnormal kidney function tests, increased salivation, hematochezia, hiccups, dizziness, asthma, exertional dyspnea, cough, bronchitis, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, arrhythmia, exacerbation of hypertension, aortic stenosis, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, dry mouth, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, hiccups, cholecystitis, paralytic ileus, abnormal kidney function tests, hematochezia, urticaria, rash, increased sweating, drowsiness, insomnia, loss of appetite, anxiety, depression, nervousness, emotional instability, hallucinations, depersonalization

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent airflow and ideally kept at a temperature between 1 degree and 30 degrees Celsius. Storing it this way may help maintain its effectiveness for a longer period.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.